Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Durando

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Breast (Edinburgh, Scotland)|October 19, 2005
Neoadjuvant endocrine therapy in breast cancerC Abrial, M-A Mouret-Reynier, H Curé, et al.
Oncology Research|March 25, 2006
Does survival increase in metastatic breast cancer with recently available anticancer drugs?C Abrial, M Leheurteur, A Cabrespine, et al.
Breast (Edinburgh, Scotland)|August 20, 2011
Late lines of treatment benefit survival in metastatic breast cancer in current practice?E Planchat, C Abrial, E Thivat, et al.
Cancer Investigation|October 21, 2011
Prognostic value of initial tumor parameters after metastatic relapseE Planchat, X Durando, C Abrial, et al.
Oncology|November 7, 2012
Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errorsE Thivat, I Van Praagh, A Belliere, et al.
Bone Marrow Transplantation|April 15, 2003
High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patientsX Durando, J-J Lemaire, J Tortochaux, et al.
Annals of Surgical Oncology|May 2, 2009
Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patientsP Gimbergues, C Abrial, X Durando, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 31, 2006
Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk categoryP Gimbergues, M M Dauplat, A Cayre, et al.
Annals of Surgical Oncology|March 4, 2008
Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentationP Gimbergues, C Abrial, X Durando, et al.
Annals of Surgical Oncology|February 16, 2010
Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patientsP Gimbergues, M M Dauplat, X Durando, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Breast (Edinburgh, Scotland)|October 19, 2005
Neoadjuvant endocrine therapy in breast cancerC Abrial, M-A Mouret-Reynier, H Curé, et al.
Oncology Research|March 25, 2006
Does survival increase in metastatic breast cancer with recently available anticancer drugs?C Abrial, M Leheurteur, A Cabrespine, et al.
Breast (Edinburgh, Scotland)|August 20, 2011
Late lines of treatment benefit survival in metastatic breast cancer in current practice?E Planchat, C Abrial, E Thivat, et al.
Cancer Investigation|October 21, 2011
Prognostic value of initial tumor parameters after metastatic relapseE Planchat, X Durando, C Abrial, et al.
Oncology|November 7, 2012
Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errorsE Thivat, I Van Praagh, A Belliere, et al.
Bone Marrow Transplantation|April 15, 2003
High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patientsX Durando, J-J Lemaire, J Tortochaux, et al.
Annals of Surgical Oncology|May 2, 2009
Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patientsP Gimbergues, C Abrial, X Durando, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 31, 2006
Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk categoryP Gimbergues, M M Dauplat, A Cayre, et al.
Annals of Surgical Oncology|March 4, 2008
Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentationP Gimbergues, C Abrial, X Durando, et al.
Annals of Surgical Oncology|February 16, 2010
Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patientsP Gimbergues, M M Dauplat, X Durando, et al.
Pageof 3